Uncategorized

Risk-Based Selection for Active Surveillance

Feb 9, 2018 by in Uncategorized Comments Off on Risk-Based Selection for Active Surveillance

Fig. 6.1 Definition of overdiagnosis (From Etzoioni [55]. Used with permission) Fig. 6.2 Association of different treatment strategies with life expectancy and risk of PCa progression. The downhill slope between…

read more

Tissue-Based Markers for Risk Prediction

Feb 9, 2018 by in Uncategorized Comments Off on Tissue-Based Markers for Risk Prediction

Company/test name Molecular type Primary endpoints Prolaris – cell cycle progression Gene expression (RNA quantification) Risk of biochemical recurrence, metastasis, and disease-specific mortality Genome DX – Decipher biopsy Gene expression (RNA quantification)…

read more

Research Questions in Active Surveillance

Feb 9, 2018 by in Uncategorized Comments Off on Research Questions in Active Surveillance

Name N Intervention Outcome Nordic lifestyle 2011 24 Vigorous exercise > = 3 ×/week, rye PCa progression Diet in PCa 2011 464 Dietary education and telephone counseling × 2 years Clinical progression, TTP…

read more

Is There a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of 5-ARIs, Statins, and Metformin

Feb 9, 2018 by in Uncategorized Comments Off on Is There a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of 5-ARIs, Statins, and Metformin

© Springer International Publishing AG 2018Laurence Klotz (ed.)Active Surveillance for Localized Prostate CancerCurrent Clinical Urologydoi.org/10.1007/978-3-319-62710-6_17 17. Is There a Role for Pharmacologic Manipulation to Prevent Progression in Men on Active Surveillance? The Role of…

read more
Premium Wordpress Themes by UFO Themes